Wells Fargo & Company »

Rapt Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $310k 13k 24.85
2023-09-30 $470k 28k 16.62
2023-06-30 $704k 38k 18.70
2022-09-30 $19k 769 24.92
2022-06-30 $10k 565 17.70
2022-03-31 $139k 6.3k 21.97
2021-12-31 $489k 13k 36.70
2021-09-30 $8.6k 283 30.30
2021-06-30 $14k 450 31.11
2021-03-31 $58k 2.7k 21.94
2020-12-31 $596k 30k 19.71
2020-09-30 $1.6M 50k 32.16
2020-06-30 $1.2M 42k 28.97
2020-03-31 $283k 13k 21.21
2019-12-31 $230k 9.7k 23.81